Biomarker discovery and development of therapy for aortic aneurysm

Biomarker discovery and development of therapy for aortic aneurysm - Biomarker discovery and development of therapy for aortic aneurysm

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000010927

Enrollment

150

Registered

2013-06-12

Start date

2013-06-12

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic aneurysm

Interventions

Blood samples (5 ml per patient) are obtained from patients with aortic aneurysm. Aortic aneurysmal tissues are obtained at surgeres of blood vessel prosthesis implantation.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients over 20 years old.

Exclusion criteria

Exclusion criteria: N/A

Design outcomes

Primary

Measure	Time frame
1. Detection of biomarkers that correlate with activity and progression of aortic aneurysm. 2. Identification of proteins that contribute to progression of aortic aneurysm using organ culture of aortic tissues. 3. Development of drugs that inhibit the identified proteins.	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026